(Q44168562)

30 November 2017

Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis. (English)

1 reference

30 November 2017

Y Remvikos

1

1 reference

30 November 2017

M Gerbault-Seureau

2

1 reference

30 November 2017

H Magdelénat

3

1 reference

30 November 2017

M Prieur

4

1 reference

30 November 2017

B Dutrillaux

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 January 1992

1 reference

Breast Cancer Research and Treatment

30 November 2017

1 reference

30 November 2017

23

1 reference

30 November 2017

43-49

1 reference

30 November 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01831474

30 November 2017

0 references

cites work

Progesterone receptors as a prognostic factor in Stage II breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FBF01831474

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01831474

Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01831474

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01831474

21 January 2018

Identifiers

DOI

10.1007/BF01831474

1 reference

30 November 2017

1 reference